Launch of Protocol AI: A huge success with exciting opportunities ahead

Thank you once again for joining us at the Protocol AI launch event. We were thrilled to welcome 273 participants, both online and onsite, and received a high number of demo requests post-event. Your enthusiastic participation and interest were evident and greatly appreciated. 

Below, you'll find links to articles covering the event.

• https://www.fiercebiotech.com/cro/risklick-debuts-new-ai-software-writes-clinical-trial-protocols
• https://www.startupticker.ch/en/news/risklick-launches-flagship-product-following-an-investment-by-debiopharm
• https://www.prnewswire.com/news-releases/risklick-protocol-ai-accelerates-clinical-trial-development-and-patient-access-to-therapies-302124812.html
• https://businessnewsthisweek.com/technology/risklick-launches-protocol-ai/
• https://www.vktr.com/the-wire/risklick-protocol-ai-accelerates-clinical-trial-development-and-patient-access-to-therapies/
• https://www.vbdata.cn/newsDetail/54932410021e11efbc8000163e034e34
• https://www.dgkl.de/aktuelles/unsere-news/detail?tx_news_pi1%5Bnews%5D=265&cHash=a69fc9776c07d52c048c6f05207b26fb